NPTX2通过METTL3介导的SNAIL N6-甲基腺苷甲基化促进皮肤鳞状细胞癌上皮-间充质转化
本研究探讨NPTX2在皮肤鳞状细胞癌(cSCC)中的作用及机制,发现NPTX2在cSCC皮损和细胞系中过表达,体外促进A431和SCL-1细胞增殖、迁移、侵袭、集落形成及上皮-间充质转化,机制上NPTX2与METTL3互作并促进METTL3介导的SNAIL N6-甲基腺苷修饰,体内实验验证NPTX2的致癌作用。
要点
- NPTX2在cSCC皮损和细胞系中过表达,体外促进A431和SCL-1细胞增殖、迁移、侵袭、集落形成及上皮-间充质转化。
- NPTX2与METTL3互作,增加METTL3表达,并促进METTL3介导的SNAIL N6-甲基腺苷修饰。
- 敲低METTL3和抑制N6-甲基腺苷可逆转NPTX2过表达对cSCC细胞的影响,体内实验验证NPTX2的致癌作用。
核心结论
- NPTX2可能成为cSCC的潜在治疗靶点。
研究设计与样本
- 研究采用体外细胞实验(A431和SCL-1细胞)和体内研究,检测NPTX2在cSCC皮损和细胞系中的表达,并探讨其与METTL3及N6-甲基腺苷修饰的机制。
主要发现
- NPTX2在cSCC皮损和细胞系中过表达。
- 体外实验中,NPTX2促进A431和SCL-1细胞增殖、迁移、侵袭、集落形成和上皮-间充质转化。
- NPTX2与METTL3互作,增加METTL3表达,并提高cSCC细胞系中N6-甲基腺苷修饰水平。
- 机制上,NPTX2通过促进METTL3介导的SNAIL N6-甲基腺苷修饰来促进上皮-间充质转化。
- 敲低METTL3和抑制N6-甲基腺苷可逆转NPTX2过表达对cSCC细胞的影响,体内研究验证NPTX2作为cSCC的致癌基因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cutaneous squamous cell carcinoma (cSCC) is the second most common type of skin cancer. NPTX2, a member of the neuronal pentraxin family, is reported to play inconsistent roles in different cancers. The role and mechanism of NPTX2 in cSCC remain unclear. In this study, we found that NPTX2 was overexpressed in both skin lesions and cell lines of cSCC. In vitro studies showed that NPTX2 facilitated cell proliferation, migration, invasion, colony formation, and epithelial‒mesenchymal translation in A431 and SCL-1 cells. NPTX2 interacted with METTL3, increased METTL3 expression, and improved N6-methyladenosine modification in cSCC cell lines. Mechanistically, NPTX2 facilitated epithelial‒mesenchymal translation by promoting METTL3-mediated N6-methyladenosine of SNAIL. METTL3 knockdown and N6-methyladenosine inhibition reversed the impacts of NPTX2 overexpression on cSCC cells. In vivo studies verified the role of NPTX2 as an oncogene in cSCC. Therefore, NPTX2 may be a potential therapeutic target for cSCC.
引用
- Kang T, Zhang C, Lei H, et al. NPTX2 Promotes Epithelial-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma through METTL3-Mediated N6-Methyladenosine Methylation of SNAIL. J Invest Dermatol. 2023. PMID: 36638907. doi:10.1016/j.jid.2022.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。